These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 4989718)
21. Orally-administered silver sulfadiazine: chemotherapy and toxicology in CF-1 mice; Plasmodium berghei (Malaria) and Pseudomonas aeruginosa. Wysor MS Chemotherapy; 1975; 21(5):302-10. PubMed ID: 807459 [TBL] [Abstract][Full Text] [Related]
22. The behavior of mafenide acetate as a basis for its clinical use. Harrison HN; Bales H; Jacoby F Arch Surg; 1971 Oct; 103(4):449-53. PubMed ID: 5094550 [No Abstract] [Full Text] [Related]
23. Inhibition of supraeschar and subeschar Pseudomonas infection by silver sulfadiazine dry foam. Catania PN; King JC J Pharm Sci; 1975 Mar; 64(3):457-8. PubMed ID: 807702 [TBL] [Abstract][Full Text] [Related]
24. Comparison between Alpha and silver sulfadiazine ointments in treatment of Pseudomonas infections in 3rd degree burns. Hosseini SV; Tanideh N; Kohanteb J; Ghodrati Z; Mehrabani D; Yarmohammadi H Int J Surg; 2007 Feb; 5(1):23-6. PubMed ID: 17386910 [TBL] [Abstract][Full Text] [Related]
25. Lung bacterial clearance in the burned rat. Skornik WA; Dressler DP Ann Surg; 1970 Nov; 172(5):837-43. PubMed ID: 4991087 [No Abstract] [Full Text] [Related]
26. Protection against Pseudomonas aeruginosa infection by immunisation with fractions of culture filtrates of Ps. aeruginosa. Jones RJ Br J Exp Pathol; 1968 Oct; 49(5):411-20. PubMed ID: 4973304 [No Abstract] [Full Text] [Related]
27. Mechanisms of in vitro sensitivity to sulfadiazine silver. McManus AT; Denton CL; Mason AD Arch Surg; 1983 Feb; 118(2):161-6. PubMed ID: 6401421 [TBL] [Abstract][Full Text] [Related]
28. Topical therapy and the development of silver sulfadiazine. Fox CL Surg Gynecol Obstet; 1983 Jul; 157(1):82-8. PubMed ID: 6857475 [TBL] [Abstract][Full Text] [Related]
29. Clinical experience with silver sulfadiazine, a new topical agent for control of pseudomonas infections in burns. Stanford W; Rappole BW; Fox CL J Trauma; 1969 May; 9(5):377-88. PubMed ID: 5771755 [No Abstract] [Full Text] [Related]
30. Alternate case study of topical sulfamylon and silver sulfadiazine in burns. Ollstein RN; Symonds FC; Crikelair GF; Pelle L Plast Reconstr Surg; 1971 Oct; 48(4):311-7. PubMed ID: 5097738 [No Abstract] [Full Text] [Related]
32. [Silver sulphadiazine cream in the treatment of chronic Pseudomonas infection of the external auditory canal in fifteen dogs (author's transl)]. van den Bogaard AE; Maes JH; Simons HP Tijdschr Diergeneeskd; 1982 Mar; 107(6):224-8. PubMed ID: 6801814 [No Abstract] [Full Text] [Related]
34. Control of experimental burn wound infections: comparative delivery of the antimicrobial agent (silver sulfadiazine) either from a cream base or from a solid synthetic dressing. Robb EC; Nathan P J Trauma; 1981 Oct; 21(10):889-93. PubMed ID: 7277534 [TBL] [Abstract][Full Text] [Related]
35. Effect of silver lactate and silver sulfadiazine on experimental burn wound sepsis. Cossman DV; Krizek TJ Surg Forum; 1971; 22():495-7. PubMed ID: 5121452 [No Abstract] [Full Text] [Related]
36. Mafenide hydrochloride and mafenide acetate in spray and ointment forms as topical therapy of C. perfringens contaminated massive wounds: experimental study. Mendelson JA; Pratt HJ; Amato JJ; Lieberman MK; Hamm TE; Gruber RP; Brinkley FB; Heitkamp DH; Healy MJ J Trauma; 1970 Dec; 10(12):1132-44. PubMed ID: 4320694 [No Abstract] [Full Text] [Related]
37. Formulation and in vitro evaluation of anti-infective dry foams. Catania PN; King JC J Pharm Sci; 1974 Sep; 63(9):1483-4. PubMed ID: 4214918 [No Abstract] [Full Text] [Related]
38. Combined use of topical cyclosporin A and silver sulphadiazine on allografts infected with Pseudomonas in burned rats. Lai CS; Miskell P; Gonce SJ; Alexander JW; Babcock GF Burns Incl Therm Inj; 1987 Jun; 13(3):181-4. PubMed ID: 3111646 [TBL] [Abstract][Full Text] [Related]